cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling

American Journal of Physiology. Lung Cellular and Molecular Physiology
Peter G PhillipsN W Morrell

Abstract

We investigated the effects of prostacyclin analogs and isoform-selective phosphodiesterase (PDE) inhibitors, alone and in combination, on pulmonary vascular remodeling in vitro and in vivo. Vascular smooth muscle cells (VSMC) isolated from pulmonary (proximal and distal) and systemic circulations demonstrated subtle variations in expression of PDE isoform mRNA. However, using biochemical assays, we found PDE3 and PDE4 isoforms to be responsible for the majority of cAMP hydrolysis in all VSMC. In growth assays, the prostacyclin analogs cicaprost and iloprost inhibited mitogen-induced proliferation of VSMC in a cAMP-dependent manner. In addition, isoform-selective antagonists of PDEs 1, 3, or 4 inhibited VSMC proliferation, an effect that synergized with the effect of prostacyclin analogs. The inhibitory effects were greater in cells isolated from pulmonary circulation. In an in situ perfused rat lung preparation, administration of prostacyclin analogs or the PDE inhibitors vinpocetine (PDE1), cilostamide (PDE3), or rolipram (PDE4), but not EHNA (PDE2), attenuated acute hypoxic vasoconstriction (HPV). Combinations of agents led to a greater reduction in HPV. Furthermore, during exposure to hypoxia for 13 days, Wistar rats were t...Continue Reading

References

Oct 1, 1992·Trends in Biochemical Sciences·M Karin, T Smeal
Jan 1, 1992·British Journal of Pharmacology·J C Wanstall, S R O'Donnell
Jul 9, 1992·The New England Journal of Medicine·B W ChristmanJ E Loyd
Dec 1, 1989·American Journal of Respiratory Cell and Molecular Biology·D B BadeschK R Stenmark
May 1, 1994·The American Journal of Physiology·K F RabeH Magnussen
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Feb 2, 1996·The Journal of Biological Chemistry·L DésaubryR A Johnson
Aug 1, 1996·The American Journal of Physiology·L ZhaoM R Wilkins
Mar 27, 1998·Cell Biochemistry and Biophysics·R HoffmannP Engels
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·R M TuderN F Voelkel
Mar 14, 2000·Current Opinion in Cell Biology·S H Soderling, J A Beavo
Nov 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·R T SchermulyD Walmrath
Mar 14, 2002·Current Opinion in Cell Biology·Manuela ZaccoloTullio Pozzan
Jan 15, 2003·Progress in Cardiovascular Diseases·T K Jeffery, N W Morrell
Sep 4, 2003·The European Respiratory Journal·R T SchermulyD Walmrath

❮ Previous
Next ❯

Citations

Jul 1, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Madelyn S HansonRandy S Sprague
Mar 3, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Shaquria P AdderleyRandy S Sprague
Sep 29, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yvonne P de VisserGerry T M Wagenaar
Sep 11, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M Cecilia Ortiz-CapisanoWilliam H Beierwaltes
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·John WhartonMartin R Wilkins
Feb 24, 2006·American Journal of Respiratory and Critical Care Medicine·Marius M Hoeper, Lewis J Rubin
Nov 3, 2005·Respiratory Research·Soni PullamsettiRalph Theo Schermuly
Apr 16, 2011·PloS One·Xia TianSoni Savai Pullamsetti
Dec 20, 2008·Heart Failure Reviews·Matthew MovsesianMichael R Bristow
Oct 4, 2011·Current Opinion in Pharmacology·Stefan Chan, Chen Yan
Nov 22, 2005·Paediatric Respiratory Reviews·Luke S G E Howard, Nicholas W Morrell
Jun 25, 2008·Chest·Steven K Huang, Marc Peters-Golden
Mar 9, 2005·Critical Care Medicine·Stuart M Lowson
Mar 3, 2010·Pediatric Pulmonology·Irene W J M van der HorstBernard Thébaud
Aug 8, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mark KirschHarald H H W Schmidt
Mar 3, 2019·British Journal of Pharmacology·Liang ZhangVéronique Leblais
Oct 11, 2014·British Journal of Pharmacology·Andreas PapapetropoulosStavros Topouzis
Jul 16, 2010·Pharmacological Reports : PR·Shaquria P AdderleyMadelyn S Hanson
Feb 5, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lucia De FranceschiCarlo Brugnara
Mar 10, 2011·British Journal of Pharmacology·K T SanthoshS Dakshinamurti
Sep 12, 2020·Physiological Reports·Julie DillardBernadette Chen
Aug 19, 2007·The FEBS Journal·Torsten R Dunkern, Armin Hatzelmann
Apr 24, 2009·The Journal of Pharmacology and Experimental Therapeutics·Mohamed IzikkiSaadia Eddahibi
Mar 25, 2009·Pharmacology & Therapeutics·Emily J Tsai, David A Kass

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.